LAUSR

Amenorrhea secondary to vismodegib: An adverse event to consider especially in female patients with Gorlin‐Goltz syndrome

Sign Up to like & get
recommendations!
0 Published in 2020 at "Dermatologic Therapy"

DOI: 10.1111/dth.13527

Abstract: Dear Editor, Vismodegib, a first-in-class inhibitor of the hedgehog signaling pathway, is indicated to treat metastatic or locally advanced basal cell carcinoma (BCC). Mutations in Patched 1 (PTCH1) and smoothened (SMO) proteins of the Hedgehog… read more here.

Keywords: amenorrhea secondary; goltz syndrome; vismodegib; gorlin goltz ... See more keywords